<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04084925</url>
  </required_header>
  <id_info>
    <org_study_id>M258</org_study_id>
    <nct_id>NCT04084925</nct_id>
  </id_info>
  <brief_title>HOMA-IR as a Screening Test in NAFLD</brief_title>
  <official_title>Is HOMA-IR(Homeostatic Model Assessment for Insulin Resistance) a Potential Screening Test for Non-alcoholic Fatty Liver Disease in Adults With Type 2 DM?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fayoum University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fayoum University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the role of HOMA-IR in diagnosis of NAFLD in patients
      with type 2 DM.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      this study is a retrospective cohort study included 100 patients with type 2 DM from the
      outpatient clinic of internal medicine department at Fayoum University Hospital. They were
      divided into two equal groups according to the presence of NAFLD by ultrasound. All patients
      were subjected to history taking, clinical examination and investigations which included:
      ALT, AST, total cholesterol, TG, FBG and fasting insulin level,HOMA-IR(Homeostatic Model
      Assessment for Insulin Resistance) assessment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2017</start_date>
  <completion_date type="Actual">December 20, 2018</completion_date>
  <primary_completion_date type="Actual">June 20, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The correlation between HOMA-IF and NAFLD</measure>
    <time_frame>6 months</time_frame>
    <description>Find a statistically significant correlation between HOMA IR and NAFLD in diabetics</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">100</enrollment>
  <condition>NAFLD</condition>
  <arm_group>
    <arm_group_label>Diabetics with NAFLD</arm_group_label>
    <description>Diabetics whose abdominal ultrasound showed that they have NAFLD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diabetics without NAFLD</arm_group_label>
    <description>Diabetics whose abdominal ultrasound showed that they do not have NAFLD</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with type 2 diabetes mellitus from the outpatient clinic of internal medicine
        department at Fayoum University Hospital
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Diabetes obesity

        Exclusion Criteria:

          -  use of alcohol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohammed A Mashaheet, MD</last_name>
    <role>Study Director</role>
    <affiliation>Faculty of medicine Fayoum university</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fayoum university hospital</name>
      <address>
        <city>Fayoum</city>
        <zip>63514</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 3, 2019</study_first_submitted>
  <study_first_submitted_qc>September 7, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 10, 2019</study_first_posted>
  <last_update_submitted>September 10, 2019</last_update_submitted>
  <last_update_submitted_qc>September 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fayoum University</investigator_affiliation>
    <investigator_full_name>Ahmed Abdelkawi Hammad</investigator_full_name>
    <investigator_title>Lecturer of internal medicine-Faculty of medicine -Fayoum university</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

